AIDS Patients Frequently Troubled by Fat Malabsorption
WESTPORT, Conn-A new study is urging physicians to pay more attention to AIDS patients who suffer from diarrhea. Chances are, they are suffering from fat malabsorption caused by their highly active antiretroviral therapy (HAART) and other drugs to treat AIDS.
A group of researchers from the University of California at Los Angeles (UCLA) reviewed 33 cases of fat malabsorption in HIV-infected patients who were troubled with diarrhea. While 12 of the group members were taking HAART medications, 21 were taking nucleoside analogs. Within the group, all but three were suffering from fat malabsoprtion.
The condition is usually a sign of pancreatic failure and physicians often do not think to diagnose their HIV-positive and AIDS patients with something that with traditional thinking, they shouldn't have. However, many AIDS patients have had pancreatic damage when examined post mortem. The study goes on to discuss the possibility of these drugs causing pancreatic damage, leading to fat malabsoprtion.
Information from www.givenimaging.com, Reuters Health
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
